Nisa Investment Advisors, LLC Chemo Centryx, Inc. Transaction History

Nisa Investment Advisors, LLC

$24.1 Billion
Q4 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Apr 29, 2022	SELL	$22.22 - $39.12 $49,506 - $87,159	-2,228 Reduced 45.58%	2,660 $67,000
Q4 2021 Feb 03, 2022	BUY	$18.38 - $40.5 $28,636 - $63,099	1,558 Added 46.79%	4,888 $131,000
Q2 2021 Aug 06, 2021	BUY	$9.59 - $50.88 $11,508 - $61,056	1,200 Added 56.34%	3,330 $45,000
Q4 2020 Jan 25, 2021	BUY	$47.25 - $65.16 $16,537 - $22,806	350 Added 19.66%	2,130 $132,000
Q3 2020 Oct 20, 2020	BUY	$46.35 - $61.69 $62,572 - $83,281	1,350 Added 313.95%	1,780 $98,000
Q2 2020 Jul 27, 2020	BUY	$38.58 - $65.07 $3,858 - $6,506	100 Added 30.3%	430 $25,000
Q1 2020 Apr 17, 2020	BUY	$32.73 - $50.78 $10,800 - $16,757	330 New	330 $13,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.